197 related articles for article (PubMed ID: 23554831)
1. A laboratory evaluation of medicinal herbs used in china for the treatment of hand, foot, and mouth disease.
Chen X; Wang C; Xu L; Chen X; Wang W; Yang G; Tan RX; Li E; Jin Y
Evid Based Complement Alternat Med; 2013; 2013():504563. PubMed ID: 23554831
[TBL] [Abstract][Full Text] [Related]
2. Glycyrrhizic acid as the antiviral component of Glycyrrhiza uralensis Fisch. against coxsackievirus A16 and enterovirus 71 of hand foot and mouth disease.
Wang J; Chen X; Wang W; Zhang Y; Yang Z; Jin Y; Ge HM; Li E; Yang G
J Ethnopharmacol; 2013 May; 147(1):114-21. PubMed ID: 23454684
[TBL] [Abstract][Full Text] [Related]
3. Anti-enterovirus 71 activity screening of chinese herbs with anti-infection and inflammation activities.
Lin TY; Liu YC; Jheng JR; Tsai HP; Jan JT; Wong WR; Horng JT
Am J Chin Med; 2009; 37(1):143-58. PubMed ID: 19222118
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice.
Sun S; Jiang L; Liang Z; Mao Q; Su W; Zhang H; Li X; Jin J; Xu L; Zhao D; Fan P; An D; Yang P; Lu J; Lv X; Sun B; Xu F; Kong W; Jiang C
Hum Vaccin Immunother; 2014; 10(10):2885-95. PubMed ID: 25483672
[TBL] [Abstract][Full Text] [Related]
5. Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.
Lyu K; He YL; Li HY; Chen R
J Virol; 2015 Jun; 89(12):6196-208. PubMed ID: 25833050
[TBL] [Abstract][Full Text] [Related]
6. Etiology of Multiple Non-EV71 and Non-CVA16 Enteroviruses Associated with Hand, Foot and Mouth Disease in Jinan, China, 2009-June 2013.
Guan H; Wang J; Wang C; Yang M; Liu L; Yang G; Ma X
PLoS One; 2015; 10(11):e0142733. PubMed ID: 26562154
[TBL] [Abstract][Full Text] [Related]
7. Understanding the epidemiological characteristics of EV71 and CVA16 infection to aid the diagnosis and treatment of hand, foot, and mouth disease.
Wang B; Li J; Wang Y; Du N; Sun L; Xiao H; Zhao Y; Bao W; Zhang W
J Med Virol; 2019 Feb; 91(2):201-207. PubMed ID: 30118553
[TBL] [Abstract][Full Text] [Related]
8. Antiviral effects of the petroleum ether extract of
Huang X; Li J; Hong Y; Jiang C; Wu J; Wu M; Sheng R; Liu H; Sun J; Xin Y; Su W
Front Pharmacol; 2022; 13():999798. PubMed ID: 36523495
[TBL] [Abstract][Full Text] [Related]
9. Serum cholinesterase: a potential assistant biomarker for hand, foot, and mouth disease caused by enterovirus 71 infection.
Cheng BN; Jin YL; Chen BQ; Zhu LY; Xu ZC; Shen T
Infect Dis Poverty; 2016 Mar; 5():27. PubMed ID: 27025584
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of a Trivalent Hand, Foot, and Mouth Disease Vaccine against Enterovirus 71 and Coxsackieviruses A16 and A6 in Mice.
Caine EA; Fuchs J; Das SC; Partidos CD; Osorio JE
Viruses; 2015 Nov; 7(11):5919-32. PubMed ID: 26593938
[TBL] [Abstract][Full Text] [Related]
11. [Detection of enterovirus 71 and coxsackievirus A16 from children with hand, foot and mouth disease in Shanghai, 2002].
Yang ZH; Zhu QR; Li XZ; Wang XH; Wang JS; Hu JY; Tang W; Cui AL
Zhonghua Er Ke Za Zhi; 2005 Sep; 43(9):648-52. PubMed ID: 16191294
[TBL] [Abstract][Full Text] [Related]
12. Lycorine Derivative LY-55 Inhibits EV71 and CVA16 Replication Through Downregulating Autophagy.
Wang H; Guo T; Yang Y; Yu L; Pan X; Li Y
Front Cell Infect Microbiol; 2019; 9():277. PubMed ID: 31448243
[TBL] [Abstract][Full Text] [Related]
13. Characterization of enterovirus 71 and coxsackievirus A16 isolated in hand, foot, and mouth disease patients in Guangdong, 2010.
He SJ; Han JF; Ding XX; Wang YD; Qin CF
Int J Infect Dis; 2013 Nov; 17(11):e1025-30. PubMed ID: 23791223
[TBL] [Abstract][Full Text] [Related]
14.
Meng T; Jia Q; Wong SM; Chua KB
J Virol; 2019 Sep; 93(17):. PubMed ID: 31167919
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Coxsackievirus A6- and Enterovirus 71-Associated Hand Foot and Mouth Disease in Beijing, China, from 2013 to 2015.
Li J; Sun Y; Du Y; Yan Y; Huo D; Liu Y; Peng X; Yang Y; Liu F; Lin C; Liang Z; Jia L; Chen L; Wang Q; He Y
Front Microbiol; 2016; 7():391. PubMed ID: 27065963
[TBL] [Abstract][Full Text] [Related]
16. [Epidemiological features and pathogenic characteristics of hand, foot and mouth disease in Gansu Province, China during 2008-2012].
Yu DS; Zhang Y; Chen JH; Duan LP; Zhao XH; Li XL; Sun Q; Chen X; Liu JF; Zheng YH; Meng L
Bing Du Xue Bao; 2014 Jan; 30(1):25-32. PubMed ID: 24772894
[TBL] [Abstract][Full Text] [Related]
17. Analysis and solution of false-positives when testing CVA16 sera using an antibody assay against the EV71 virus.
Wang C; You A; Tian X; Zhao M; Chen Y; Lin T; Zheng J; Xiao M; Zhang Y; Kuang L; Zhou Z; Zhu B
Virus Res; 2013 Sep; 176(1-2):33-6. PubMed ID: 23707400
[TBL] [Abstract][Full Text] [Related]
18. Phage Display-Derived Cross-Reactive Neutralizing Antibody against Enterovirus 71 and Coxsackievirus A16.
Zhang X; Sun C; Xiao X; Pang L; Shen S; Zhang J; Cen S; Yang BB; Huang Y; Sheng W; Zeng Y
Jpn J Infect Dis; 2016; 69(1):66-74. PubMed ID: 26073737
[TBL] [Abstract][Full Text] [Related]
19. Complete sequence analysis and antiviral screening of medicinal plants for human coxsackievirus a16 isolated in Korea.
Song JH; Park K; Shim A; Kwon BE; Ahn JH; Choi YJ; Kim JK; Yeo SG; Yoon K; Ko HJ
Osong Public Health Res Perspect; 2015 Feb; 6(1):52-8. PubMed ID: 25737832
[TBL] [Abstract][Full Text] [Related]
20. Type I Interferons Triggered through the Toll-Like Receptor 3-TRIF Pathway Control Coxsackievirus A16 Infection in Young Mice.
Yang J; Yang C; Guo N; Zhu K; Luo K; Zhang N; Zhao H; Cui Y; Chen L; Wang H; Gu J; Ge B; Qin CF; Leng Q
J Virol; 2015 Nov; 89(21):10860-7. PubMed ID: 26292317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
